SCM to Unveil Formulation Service
UK-based SCM Pharma is set to officially launch its own formulation development capability after acquiring new facilities as part of a collaborative deal with the University of Sunderland.
UK-based SCM Pharma is set to officially launch its own formulation development capability after acquiring new facilities as part of a collaborative deal with the University of Sunderland.
Using the most advanced proven technology in evaporation science, the Genevac EZ-2 Series has proven itself as a popular centrifugal evaporator for QA and research labs worldwide, be that for concentration of samples or complete drying.
During an interview with Mr. George Syrmalis CEO, it does not take long for his enthusiasm and explanation of the business model to get the mind racing. The offer has already been underwritten by Centre capital.
SPECIALITY pharmaceutical company Alliance Pharma has awarded a commercial supply contract for three of its products to sterile manufacturing expert SCM Pharma, a development and contract manufacturing organisation (CDMO).
Phage Consultants extended the services offered within contract research section. Now we offer our customers tests on mouse model of efficacy of phage preparation.
In October, GEA Niro - the world leader in spray drying technology - will be exhibiting at POWTECH/TechnoPharm in Nürnberg, Germany from the 11-13 October and CPhI in Frankfurt, Germany on the 25-27 October to promote pharmaceutical spray drying. Company representatives will be available to provide insights into the technology and its benefits, and to discuss how working with GEA Niro helps clients exploit the full potential of pharmaceutical spray drying.
Regulatory and clinical professionals, professors and students now have a comprehensive guide to the complexities of drug approval and regulation around the world, with the first edition release of CenterWatch’s Global Regulatory Systems: A Strategic Primer for Biopharmaceutical Product Development and Registration
A new CenterWatch survey released today shows contract research organisations (CROs) have continued to improve their relationships with investigative sites for the third straight year, focusing on improving project management and training their field monitors.
A new CenterWatch survey released today shows drug sponsors have continued to improve their relationships with investigative sites by focusing on strategies to improve site quality and performance.
CenterWatch today reports that the fragmented U.S. investigative site market is poised for acquisitions that may be driven by the most unlikely of sources: large European site management organizations (SMOs). The report, released in the January issue of The CenterWatch Monthly, provides an in-depth look at the infrastructure and strategies of the European companies likely to drive this wave of consolidation. The report signals opportunity and change for clinical research professionals in the U.S.